What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-20
DOI
10.1007/s40262-019-00791-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
- (2018) Nicholas M. Maurice et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- In Vivo Efficacy of Plazomicin Alone or in Combination with Meropenem or Tigecycline against Enterobacteriaceae Isolates Exhibiting Various Resistance Mechanisms in an Immunocompetent Murine Septicemia Model
- (2018) Kamilia Abdelraouf et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients
- (2018) Sofie A.M. Dhaese et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model
- (2018) Katie E Barber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model
- (2018) Iris K Minichmayr et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of piperacillin in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration
- (2018) Mahipal G Sinnollareddy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection
- (2018) Alan R Noel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quality evaluation of human and environmental toxicity studies performed with nanomaterials – the GUIDEnano approach
- (2018) M. L. Fernández-Cruz et al. Environmental Science-Nano
- Optimal Piperacillin/Tazobactam Dosing Strategies against ESBL-producing Enterobacteriaceae
- (2018) Henrietta Abodakpi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens
- (2017) Zoe Oesterreicher et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?
- (2017) Isabelle K. Delattre et al. Expert Review of Anti-Infective Therapy
- Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a ‘Goldilocks’ window
- (2017) Cristina Miglis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens
- (2017) Nathaniel J. Rhodes et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection
- (2017) Wadha A. Alfouzan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing Escherichia coli in a hollow-fibre infection model
- (2017) Rachel L. Soon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model
- (2017) Iain J Abbott et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships
- (2017) Sahand Imani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- MIC-based dose adjustment: facts and fables
- (2017) Johan W Mouton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria
- (2017) Vincent H. Tam et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Species differences in ciprofloxacin resistance among Gram-negative bacteria: can “anti-mutant” ratios of the area under the concentration–time curve to the MIC be achieved clinically?
- (2017) Elena N. Strukova et al. JOURNAL OF CHEMOTHERAPY
- Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration
- (2017) Erlangga Yusuf et al. Annals of Intensive Care
- Antibacterial activity of human simulated epithelial lining fluid concentrations of amikacin inhale alone and in combination with meropenem against Acinetobacter baumannii
- (2017) Islam M. Ghazi et al. Infectious Diseases
- Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis
- (2017) Raspail Carrel Founou et al. PLoS One
- Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model
- (2016) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study
- (2016) Ai-jun Pan et al. JOURNAL OF ANTIBIOTICS
- Effect of different renal function on antibacterial effects of piperacillin againstPseudomonas aeruginosaevaluated via the hollow-fibre infection model and mechanism-based modelling
- (2016) Phillip J. Bergen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A pharmacokinetic–pharmacodynamic model characterizing the emergence of resistantEscherichia colisubpopulations during ertapenem exposure
- (2016) Wanchana Ungphakorn et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotic Resistance and Regulation of the Gram-Negative Bacterial Outer Membrane Barrier by Host Innate Immune Molecules
- (2016) Samuel I. Miller mBio
- Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by UsingIn VitroDynamic Models
- (2015) Elena N. Strukova et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods
- (2015) Brian C. Nelson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival
- (2015) Nathaniel J. Rhodes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using anIn VitroInfection Model
- (2015) Brian D. VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
- (2015) F. Docobo-Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Fosfomycin in Critically Ill Patients
- (2015) Suzanne L. Parker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
- (2015) Ilias Karaiskos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections
- (2015) Manjunath P. Pai et al. CLINICAL PHARMACOKINETICS
- Antimicrobial resistance: A global emerging threat to public health systems
- (2015) Maurizio Ferri et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance?Pseudomonas aeruginosabloodstream infection in elderly patients as a simulation case study
- (2015) Yoann Cazaubon et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study
- (2015) B. Denis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Predictors of bacterial resistance usingin vitrodynamic models: area under the concentration–time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration
- (2015) Elena N. Strukova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia
- (2015) O. Pajot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis
- (2015) Claire Roger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of temocillin in a murine model of urinary tract infection due toEscherichia coliproducing or not producing the ESBL CTX-M-15
- (2015) J. F. Soubirou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emerging Issues in Gram-Negative Bacterial Resistance
- (2015) Shawn Vasoo et al. MAYO CLINIC PROCEEDINGS
- Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
- (2014) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Ceftolozane-Tazobactam Exposure and Selection for Pseudomonas aeruginosa Resistance in a Hollow-Fiber Infection Model
- (2014) Brian D. VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Meropenem Regimens Suppressing Emergence of Resistance in Acinetobacter baumannii with Human Simulated Exposure in anIn VitroIntravenous-Infusion Hollow-Fiber Infection Model
- (2014) Xin Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- The Impact of Variation in Renal Replacement Therapy Settings on Piperacillin, Meropenem, and Vancomycin Drug Clearance in the Critically Ill
- (2014) Janattul-Ain Jamal et al. CRITICAL CARE MEDICINE
- Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: A comparison of 0.5-h and 3-h infusions
- (2014) Michal Lipš et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies
- (2014) M. J. G. T. Vehreschild et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Improved Sensitivity for Molecular Detection of Bacterial and Candida Infections in Blood
- (2014) Andrea Bacconi et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In VitroPharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii
- (2013) Mao Hagihara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline plus Avibactam Demonstrates Bactericidal Activity against Pathogenic Anaerobic Bacteria in a One-CompartmentIn VitroPharmacokinetic/Pharmacodynamic Model
- (2013) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model
- (2013) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacterial Resistance Studies UsingIn VitroDynamic Models: the Predictive Power of the Mutant Prevention and Minimum Inhibitory Antibiotic Concentrations
- (2013) Alexander A. Firsov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Meropenem in Combination with Tobramycin in a Murine Model of Pseudomonas aeruginosa Pneumonia
- (2013) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa
- (2013) T. W. Felton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Pharmacodynamics of Antipseudomonal Cephalosporins in Patients with Ventilator-Associated Pneumonia
- (2013) Shawn H. MacVane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- The complex interactions of bacterial pathogens and host defenses
- (2013) Denise M Monack et al. CURRENT OPINION IN MICROBIOLOGY
- Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model
- (2013) W. Ni et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- ComparativeIn VitroandIn VivoEfficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa
- (2012) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The ciprofloxacin target AUC : MIC ratio is not reached in hospitalized patients with the recommended dosing regimens
- (2012) Michiel Haeseker et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Optimal Doripenem Dosing Simulations in Critically Ill Nosocomial Pneumonia Patients With Obesity, Augmented Renal Clearance, and Decreased Bacterial Susceptibility*
- (2012) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Comparative Activity of Carbapenem Testing (COMPACT) study in Germany
- (2012) Giuseppe Valenza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia
- (2012) A. E. Muller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Pharmacodynamics and Antimutant Potentials of Doripenem and Imipenem with Ciprofloxacin-Resistant Pseudomonas aeruginosa in anIn VitroModel
- (2011) Alexander A. Firsov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Different Carbapenems and Regimens of Administration on Resistance Emergence for Three Isogenic Pseudomonas aeruginosa Strains with Differing Mechanisms of Resistance
- (2010) A. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model
- (2010) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of anInVitroPharmacodynamic Model To Derive a Moxifloxacin Regimen That Optimizes Kill ofYersinia pestisand Prevents Emergence of Resistance
- (2010) A. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function
- (2010) F. Lamoth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Origins and Evolution of Antibiotic Resistance
- (2010) J. Davies et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
- (2009) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacterial ventilator-associated pneumonia: bronchoalveolar lavage results are not influenced by dilution
- (2009) Olivier Baldesi et al. INTENSIVE CARE MEDICINE
- Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model
- (2009) R. Singh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Pharmacodynamic Modeling of Aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: Identifying Dosing Regimens To Suppress Resistance Development
- (2008) V. H. Tam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
- (2008) Alexandre P. Zavascki et al. CLINICAL INFECTIOUS DISEASES
- Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study
- (2008) Arthur R.H. van Zanten et al. JOURNAL OF CRITICAL CARE
- Suboptimal Aminoglycoside Dosing in Critically Ill Patients
- (2008) Rhonda S Rea et al. THERAPEUTIC DRUG MONITORING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation